|Guidelines for good clinical practice (GCP) for trials on pharmaceutical products (WHO Technical Report Series, No. 850, 1995, Annex 3) (WHO, 1995, 36 p.)|
|5. RESPONSIBILITIES OF THE SPONSOR|
Where warranted by the number or scale of clinical trials conducted, it is recommended that the sponsor establish written standard operating procedures (SOP) to comply with Good Clinical Practice.